La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Labcorp Holdings Gestion
Gestion contrôle des critères 4/4
Le PDG Labcorp Holdings' est Adam Schechter, nommé en Nov2019, a un mandat de 4.75 ans. La rémunération annuelle totale est $ 15.98M, composée du salaire de 8.6% et des bonus 91.4%, y compris les actions et options de la société. détient directement 0.11% des actions de la société, d'une valeur de $ 21.30M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.6 ans et 9.4 ans.
Informations clés
Adam Schechter
Directeur général
US$16.0m
Rémunération totale
| Pourcentage du salaire du PDG | 8.6% |
| Durée du mandat du directeur général | 4.8yrs |
| Propriété du PDG | 0.1% |
| Durée moyenne d'occupation des postes de direction | 4.6yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 9.4yrs |
Mises à jour récentes de la gestion
Recent updates
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)
Jul 20
Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Jun 21When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$450m |
| Mar 31 2024 | n/a | n/a | US$399m |
| Dec 31 2023 | US$16m | US$1m | US$379m |
| Sep 30 2023 | n/a | n/a | US$583m |
| Jun 30 2023 | n/a | n/a | US$677m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$21m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$15m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$845m |
| Jun 30 2020 | n/a | n/a | US$362m |
| Mar 31 2020 | n/a | n/a | US$321m |
| Dec 31 2019 | US$6m | US$208k | US$824m |
| Sep 30 2019 | n/a | n/a | US$755m |
| Jun 30 2019 | n/a | n/a | US$853m |
| Mar 31 2019 | n/a | n/a | US$896m |
| Dec 31 2018 | US$301k | n/a | US$884m |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$290k | n/a | US$1b |
Rémunération vs marché: La rémunération totale de Adam ($USD 15.98M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 13.21M ).
Rémunération et revenus: La rémunération de Adam a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Adam Schechter (59 yo)
4.8yrs
Titularisation
US$15,979,355
Compensation
Mr. Adam H. Schechter serves as the President, CEO & Chairman of Laboratory Corporation of America Holdings. Mr. Adam serves as President & Chief Executive Officer at Labcorp Holdings Inc. since November...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 4.8yrs | US$15.98m | 0.11% $ 21.3m | |
| CFO & Executive VP | 10.2yrs | US$4.96m | 0.055% $ 10.5m | |
| Executive VP | 1.3yrs | US$3.80m | 0.0060% $ 1.1m | |
| EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1.3yrs | US$3.48m | 0.033% $ 6.3m | |
| Executive VP & Chief Human Resources Officer | 1.3yrs | US$2.56m | 0.00035% $ 66.9k | |
| Senior VP & Chief Accounting Officer | 5.3yrs | pas de données | 0.0025% $ 475.6k | |
| Executive VP and Chief Information & Technology Officer | 10.5yrs | US$2.70m | 0.019% $ 3.6m | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Executive VP | 5.5yrs | pas de données | 0.0067% $ 1.3m | |
| Executive VP & Chief Marketing Officer | 4.4yrs | pas de données | 0.0047% $ 903.5k | |
| Enterprise Chief Scientific Officer & Senior VP | no data | pas de données | pas de données | |
| Chief Medical Officer | 3.6yrs | pas de données | pas de données |
4.6yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Gestion expérimentée: L'équipe de direction de LH est considérée comme expérimentée (ancienneté moyenne 4.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 11.3yrs | US$15.98m | 0.11% $ 21.3m | |
| Independent Director | 11.6yrs | US$357.87k | 0.014% $ 2.7m | |
| Independent Director | 18.3yrs | US$340.73k | 0.018% $ 3.4m | |
| Lead Independent Director | 10.7yrs | US$375.73k | 0.014% $ 2.7m | |
| Independent Director | 8.5yrs | US$341.44k | 0.010% $ 1.9m | |
| Independent Director | 10.3yrs | US$330.01k | 0.010% $ 2.0m | |
| Independent Director | 4.7yrs | US$344.30k | 0.0043% $ 823.3k | |
| Independent Director | 1.2yrs | US$208.42k | 0.00087% $ 166.2k | |
| Independent Director | 3.4yrs | US$330.01k | 0.0027% $ 521.5k | |
| Independent Director | 1.8yrs | US$330.01k | 0.0016% $ 299.9k |
9.4yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de LH sont considérés comme expérimentés (ancienneté moyenne 9.4 ans).